全文获取类型
收费全文 | 4682篇 |
免费 | 275篇 |
国内免费 | 70篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 195篇 |
妇产科学 | 69篇 |
基础医学 | 557篇 |
口腔科学 | 258篇 |
临床医学 | 529篇 |
内科学 | 978篇 |
皮肤病学 | 71篇 |
神经病学 | 322篇 |
特种医学 | 329篇 |
外科学 | 582篇 |
综合类 | 74篇 |
一般理论 | 3篇 |
预防医学 | 330篇 |
眼科学 | 48篇 |
药学 | 321篇 |
肿瘤学 | 338篇 |
出版年
2021年 | 44篇 |
2020年 | 48篇 |
2019年 | 60篇 |
2018年 | 62篇 |
2017年 | 61篇 |
2016年 | 67篇 |
2015年 | 77篇 |
2014年 | 122篇 |
2013年 | 186篇 |
2012年 | 254篇 |
2011年 | 237篇 |
2010年 | 130篇 |
2009年 | 154篇 |
2008年 | 175篇 |
2007年 | 211篇 |
2006年 | 208篇 |
2005年 | 192篇 |
2004年 | 174篇 |
2003年 | 144篇 |
2002年 | 126篇 |
2001年 | 143篇 |
2000年 | 118篇 |
1999年 | 127篇 |
1998年 | 100篇 |
1997年 | 100篇 |
1996年 | 115篇 |
1995年 | 90篇 |
1994年 | 81篇 |
1993年 | 66篇 |
1992年 | 109篇 |
1991年 | 73篇 |
1990年 | 77篇 |
1989年 | 104篇 |
1988年 | 81篇 |
1987年 | 114篇 |
1986年 | 71篇 |
1985年 | 82篇 |
1984年 | 52篇 |
1983年 | 64篇 |
1982年 | 48篇 |
1981年 | 35篇 |
1980年 | 48篇 |
1979年 | 45篇 |
1978年 | 30篇 |
1977年 | 38篇 |
1976年 | 23篇 |
1975年 | 36篇 |
1974年 | 36篇 |
1973年 | 27篇 |
1970年 | 22篇 |
排序方式: 共有5027条查询结果,搜索用时 15 毫秒
1.
2.
Gutierre Marcela Usberti Telles João Paulo Mota Welling Leonardo Christiaan Rabelo Nícollas Nunes Teixeira Manoel Jacobsen Figueiredo Eberval Gadelha 《Neurosurgical review》2021,44(4):2091-2097
Neurosurgical Review - Cellular response to TBI is a mixture of excitotoxicity, neuroinflammation, and cell death. Biomarkers that can track these lesions and inflammatory processes are being... 相似文献
3.
4.
5.
6.
7.
Jens Frederik Dahlerup Bent A. Jacobsen Janneke van der Woude Lars-Åke Bark Lars L. Thomsen Stefan Lindgren 《Scandinavian journal of gastroenterology》2016,51(11):1332-1338
Objective: Iron isomaltoside (Monofer®) is a high-dose intravenous iron preparation with good tolerability and efficacy in inflammatory bowel disease (IBD) patients with iron deficiency anaemia (IDA). This trial evaluates the safety and efficacy, including effect on intact fibroblast growth factor 23 (iFGF23) of a high single dose and cumulative doses of iron isomaltoside in IBD patients with IDA.Materials and methods: The trial was a prospective, open-label, multi-centre trial conducted in IBD patients with IDA. Based upon haemoglobin (Hb) levels at baseline and weight, the patients received 1500, 2000, 2500 or 3000?mg of iron isomaltoside infused in single doses up to 2000?mg. The outcome measurements included adverse drug reactions (ADRs) and changes in haematology and biochemistry parameters.Results: Twenty-one IBD patients with IDA were enrolled, receiving 1500 (seven patients), 2000 (eight patients), 2500?mg (four patients) or 3000 (two patients) mg of iron. No serious ADRs were observed. Four patients experienced nine mild to moderate ADRs (hypersensitivity, pyrexia, vomiting, constipation, abdominal pain, dyspepsia (two events) and eye allergy (two events)). In total, 15 (75%) patients had an increase in Hb of ≥2.0?g/dL during the trial, with normalisation of ferritin. No changes in iFGF23 or clinically significant hypophosphataemia were found.Conclusion: Rapid infusions of high-dose iron isomaltoside, administered as single doses up to 2000?mg and cumulative doses up to 3000?mg, were without safety concerns and were efficacious in increasing Hb levels in IBD patients. Iron isomaltoside did not induce profound phosphate wasting via increased iFGF23 levels. 相似文献
8.
9.
Eva Marxen Liang Jin Jette Jacobsen Christian Janfelt Birgitte Hyrup Joseph A. Nicolazzo 《Pharmaceutical research》2018,35(3):70
Purpose
The purpose of this study was to assess the effect of several chemical permeation enhancers on the buccal permeability of nicotine and to image the spatial distribution of nicotine in buccal mucosa with and without buccal permeation enhancers.Methods
The impact of sodium taurodeoxycholate (STDC), sodium dodecyl sulphate (SDS), dimethyl sulfoxide (DMSO) and Azone® on the permeability of [3H]-nicotine and [14C]-mannitol (a paracellular marker) across porcine buccal mucosa was studied ex vivo in modified Ussing chambers. The distribution of nicotine, mannitol and permeation enhancers was imaged using using matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI MSI).Results
Despite STDC significantly increasing permeability of [14C]-mannitol, no enhancing effect was seen on [3H]-nicotine permeability with any of the permeation enhancers. Rather, SDS and DMSO retarded nicotine permeability, likely due to nicotine being retained in the donor compartment. The permeability results were complemented by the spatial distribution of nicotine and mannitol determined with MALDI MSI.Conclusions
The buccal permeability of nicotine was affected in an enhancer specific manner, suggesting that nicotine primarily diffuses via the transcellular pathway. MALDI MSI was shown to complement ex vivo permeability studies and to be a useful qualitative tool for visualizing drug and penetration enhancer distribution in buccal mucosa.10.